TY - CHAP
T1 - Green Techniques in Drug Discovery
T2 - Sustainable Pathways to Pharmaceutical Innovation
AU - Martis, Glanish Jude
AU - Gaonkar, Santosh L.
AU - Shimizu, Hiroki
N1 - Publisher Copyright:
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025.
PY - 2025
Y1 - 2025
N2 - Green techniques have evolved over the years in the field of synthetic organic chemistry, chemical biology and medicinal chemistry. Their impact on these diverse subjects have laid a strong foundation as their advantages reflect more than the intent for which they were first developed or introduced. Pharmaceutical innovations mainly deal with the advancements and breakthroughs in developing newer strategies and bringing out greater outcomes than persisting at present. Sustainability is the major concern for the medicinal chemists, those who work on furnishing potent drug molecules and green techniques stretch them a helping hand in reducing their efforts with the harmful effects of the solvents and other chemicals used in bulk scale. Thus, this chapter deals with the new synthetic protocols developed for producing molecules of medicinal value both in small as well as large scale. The importance and advantages can be drawn as the chapter progresses eventually.
AB - Green techniques have evolved over the years in the field of synthetic organic chemistry, chemical biology and medicinal chemistry. Their impact on these diverse subjects have laid a strong foundation as their advantages reflect more than the intent for which they were first developed or introduced. Pharmaceutical innovations mainly deal with the advancements and breakthroughs in developing newer strategies and bringing out greater outcomes than persisting at present. Sustainability is the major concern for the medicinal chemists, those who work on furnishing potent drug molecules and green techniques stretch them a helping hand in reducing their efforts with the harmful effects of the solvents and other chemicals used in bulk scale. Thus, this chapter deals with the new synthetic protocols developed for producing molecules of medicinal value both in small as well as large scale. The importance and advantages can be drawn as the chapter progresses eventually.
UR - https://www.scopus.com/pages/publications/105014210552
UR - https://www.scopus.com/pages/publications/105014210552#tab=citedBy
U2 - 10.1007/978-3-031-94090-3_12
DO - 10.1007/978-3-031-94090-3_12
M3 - Chapter
AN - SCOPUS:105014210552
T3 - Intelligent Systems Reference Library
SP - 259
EP - 274
BT - Intelligent Systems Reference Library
PB - Springer Science and Business Media Deutschland GmbH
ER -